← Open Payments lookup

SERAPHINE AGBOR: Open Payments

NPI 1427690395 · ADAMSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,573 in 62 payments from 10 companies in 2025. Trend: 2023 $894 · 2024 $1,658 · 2025 $1,573

Food & beverage: $1,560Education: $14
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$350
Vanda Pharmaceuticals Inc.10$314
ABBVIE INC.14$258
Alkermes, Inc.9$217
E.R. Squibb & Sons, L.L.C.6$166
Janssen Pharmaceuticals, Inc4$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$95
Supernus Pharmaceuticals, Inc.2$35
Teva Pharmaceuticals USA, Inc.1$24
OWP Pharmaceuticals, Inc.1$16

Products named: FANAPT, ABILIFY MAINTENA, VRAYLAR, ARISTADA, COBENFY, INVEGA SUSTENNA, CAPLYTA, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.